BridgeMD
Acetated Ringer´s solution in experimental hypovolemia
EU CTIS ID: 2023-503946-30-00
What this study is testing
To assess the duration of hemodynamic effect of bolus Ringer`s acetate
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Participant must be 18 to 40 years of age inclusive, at the time of signing the informed consent
- Participants who are overtly healthy as determined by medical evaluation including medical history, physical examination and focused cardiac ultrasound
- Female participants: Use of adequate birth control for women of childbearing potential
- Capable of giving signed informed consent as described in Appendix 1 which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol
You likely can't join if
- Any medical condition limiting physical exertional capacity or requiring regular medication (allergy and contraceptives excepted)
- Pregnancy
- Breastfeeding
- History of syncope (syncope of presumed vasovagal nature with known precipitating factor excepted)
- Any known cardiac arrhythmia
- Any drug (contraceptives excepted) used on a regular basis for a chronic condition (allergy excepted)
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.